[1] 许文婧,魏莉莉,王莹,等. 我国围生儿先天性心脏病发病率的Meta分析[J]. 国际生殖健康/计划生育杂志,2020,39(4):269-275.
DOI:10.3969/j.issn.1674-1889.2020.04.001.
[2] 陈寄梅,李守军. 先天性心脏病外科治疗中国专家共识(六):完全型房室间隔缺损[J]. 中国胸心血管外科临床杂志,2020,27(7):725-731. DOI:10.7507/1007-4848. 202004032.
[3] 中国医师协会心血管内科分会先心病工作委员会. 常见先天性心脏病介入治疗中国专家共识二、室间隔缺损介入治疗[J]. 介入放射学杂志,2011,20(2):87-92.
DOI:10.3969/j.issn.1008-794X.2011.02.002.
[4] 孟保英,吴文智,丁以群,等. 五种心脏停搏液对未成熟心肌保护效果分析[J]. 中国体外循环杂志,2017,15(3):129-132.
DOI:10.13498/j.cnki.chin.j.ecc.2017.03.01.
[5] 童易如,张溪英,高纪平,等. 磷酸肌酸钠心脏停搏液在小儿心内直视手术中的心肌保护作用[J]. 中国医师杂志,2007,9(12):1707-1708.
DOI:10.3760/cma.j.issn.1008-1372. 2007.12.061.
[6] 胡强,姚伟,于坤,等. 磷酸肌酸钠对重症心脏瓣膜手术患者心肌保护作用的临床研究[J]. 中国分子心脏病学杂志,2020,20(3):3400-3402.
DOI:10.16563/j.cnki.1671-6272. 2020.06.012.
[7] 赵卫东,李经钟,刘亚军,等. 磷酸肌酸钠对不停跳冠脉搭桥术患者心肌酶的影响[J]. 河北医药,2011,33(19):2956-2957.
DOI:10.3969/j.issn.1002-7386.2011.19.039.
[8] 胡旭东,罗涛,张武,等. 磷酸肌酸钠对瓣膜置换术患者心肌缺血再灌注损伤的治疗作用[J]. 重庆医学,2012,41(1):25-27.
DOI:10.3969/j.issn.1671-8348.2012.01.009.
[9] Yang F, Wang J, Zhai B. The myocardial
protective effect of monosodium phosphate cardioplegia in cardiopulmonary
bypass in infants with an atrial septal defect[J]. Medicine (Baltimore), 2020,
99(28): e20934. DOI: 10.1097/MD.0000000000020934.
[10] Landoni G, Zangrillo A, Lomivorotov VV,
et al. Cardiac protection with phosphocreatine: a meta-analysis[J]. Interact
Cardiovasc Thorac Surg, 2016, 23(4): 637-646. DOI: 10.1093/icvts/ivw171.
[11] 沈成,王龙,雷鸿. 磷酸肌酸在心脏瓣膜置换术中心肌保护作用的Meta分析[J]. 医学综述,2018,24(16):3273-3278.
DOI:10.3969/j.issn.1006-2084.2018.16.029.
[12] 刘发科,李新,刘继,等. 磷酸肌酸钠持续逆行灌注对心脏瓣膜置换患者缺血修饰蛋白水平影响[J]. 当代医学,2017,23(23):1-4.
DOI:10.3969/j.issn.1009-4393.2017.23.001.
[13] 白莉莉. 托马斯液联合应用康斯特保护液对离体大鼠缺血-再灌注损伤心肌酶学的影响[J]. 现代诊断与治疗,2019,30(16):2851-2852.
[14] 李敏,王慧华,李燕君. 心脏移植术后早期血肌钙蛋白水平变化及院内死亡影响因素分析[J]. 护理研究,2020,34(5):789-794.
DOI:10.12102/j.issn.1009-6493.2020.05.015.
[15] 刘月齐,王荣,陈玉婷. 急性(非)ST段抬高型心肌梗死患者心肌酶谱的动态变化及临床意义[J]. 中国实用医药,2020,15(22):46-48. DOI:10.14163/j.cnki.11-5547/r.2020. 22. 018.
[16] 邹文舟,巩彦民,刘德强,等. 利巴韦林联合磷酸肌酸钠治疗小儿病毒性心肌炎的疗效观察[J]. 国际医药卫生导报,2018,24(15):2358-2361. DOI:10.3760/cma.j.issn.1007-
1245.2018.13.040.
[17] 董静. 磷酸肌酸钠联合维生素C对病毒性心肌炎患儿心肌损伤标志物的影响[J]. 国际医药卫生导报,2018,24(20):3156-3158. DOI:10.3760/cma.j.issn.1007-1245. 2018.
20.034.
[18] 蒋敏,熊堉,边原,等. 新型冠状病毒肺炎相关心肌损伤机制及磷酸肌酸钠治疗的可行性[J]. 实用医院临床杂志,2020,17(6):227-230. DOI:10.3969/j.issn.1672-6170.
2020. 06.067.
[19] Zhang T, Gao CQ, Wang JL. Application of
combined ultrafiltration combined with negative pressure assisted venous
drainage in extracorporeal circulation in infants with open heart surgery[J].
Med J Chin People Liberation Army, 2014, 39: 57-60.
[20] Savi M, Rossi S, Bocchi L, et al.
Titanium dioxide nanoparticles promote arrhythmias via a direct interaction
with rat cardiac tissue[J]. Part Fibre Toxicol, 2014, 11 :63. DOI:
10.1186/s12989-014-0063-3.
[21] Hussain T, Dragulescu A, Benson L, et
al. Quantification and significance of diffuse myocardial fibrosis and
diastolic dysfunction in childhood hypertrophic cardiomyopathy [J]. Pediatr
Cardiol, 2015, 36(5):970-8. DOI: 10.1007/s00246-015-1107-7.
[22] 梁丽俊. 磷酸肌酸在婴幼儿室间隔缺损合并肺动脉高压体外循环手术中的心肌保护作用[J]. 中国药物与临床,2017,17(7):1010-1012.
DOI:10.11655/zgywylc2017.07.026.
[23] Heusch G. Myocardial stunning and
hibernation revisited[J]. Nat Rev Cardiol, 2021, 18(7): 522-536. DOI:
10.1038/s41569-021-00506-7.
[24] Qaed E, Wang J, Almoiliqy M, et al.
Phosphocreatine improves cardiac dysfunction by normalizing mitochondrial
respiratory function through JAK2/STAT3 signaling pathway in vivo and in
vitro[J]. Oxid Med Cell Longev, 2019, 30:6521218. DOI: 10.1155/2019/6521218.
[25] Zhang W, Li K, Ding Y, et al. Protective
effect of xinmailong injection on rats with myocardial infarction[J]. Front
Physiol, 2021, 11: 595760. DOI: 10.3389/fphys.2020.595760.
[26] Li JH, Li TT, Wu XS, et al. Effect of
gamma globulin combined with creatine phosphate on viral myocarditis[J]. Am J
Transl Res. 2021 Apr 15;13(4):3682-3688.
[27] Mingxing F, Landoni G, Zangrillo A, et
al. Phosphocreatine in cardiac surgery patients: a meta-Analysis of randomized
controlled trials[J]. J Cardiothorac Vasc Anesth, 2018, 32(2): 762-770. DOI:
10.1053/j.jvca.2017. 07.024.
[28] Gaddi AV, Galuppo P, Yang J. Creatine
phosphate administration in cell energy impairment conditions: a summary of
past and present research[J]. Heart Lung Circ, 2017, 26(10): 1026-1035. DOI:
10.1016/j.hlc.2016. 12.020.
[29] Li CL, Jia LB, Gao J, et al. The
efficacy observation of ulinastatin combined with creatine phosphate sodium in
pediatric viral myocarditis[J]. Eur Rev Med Pharmacol Sci, 2019,
23(16):7144-7151. DOI: 10.26355/eurrev_201908_18760.
[30] Brewster LM. Creatine kinase, energy
reserve, and hypertension: from bench to bedside[J]. Ann Transl Med, 2018,
6(15): 292. DOI: 10.21037/atm.2018.07.15. |